Greg Lea is listed as an executive officer and director on 13 SEC Form D filings by 2 issuers between Feb 2009 and Jan 2026: ReShape Lifesciences Inc. (San Clemente, CA — other health care — 2009; $61M reported sold to 41 investors) and Ambient Clinical Analytics, Inc. (Rochester, MN — other health care — 2014–2026; $3.93M reported sold to 38 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $64.9M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 13 public filings for Greg Lea and found 7 differences, 1 worth asking the sponsor about: Paid seller listed without a CRD number: Transworld Business Advisors; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.